Home > > > > Report Detail

Global Recombinant DNA Technology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 119
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant DNA Technology companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Recombinant DNA Technology market. Further, it explains the major drivers and regional dynamics of the global Recombinant DNA Technology market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Monsanto Company

- Roche

- Biogen

- Amgen

- Novartis

- Eli Lilly and Company

- GenScript

- Pfizer Inc.

- Novo Nordisk

- Sanofi

- Merck KGaA

- Profacgen

- Biocon

- GlaxoSmithKline

- Cibus

- Horizon Discovery Group

- New England Biolabs

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Recombinant DNA Technology Segment by Type

- Therapeutic Agent

- Vaccine

- Biotech Crops

- Specialty Chemicals

Recombinant DNA Technology Segment by Application

- Biotechnology and Pharmaceutical Companies

- Academic & Government Research Institutes

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Recombinant DNA Technology market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Recombinant DNA Technology market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Recombinant DNA Technology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant DNA Technology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant DNA Technology revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant DNA Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Recombinant DNA Technology revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc.

Global Recombinant DNA Technology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Recombinant DNA Technology Market Size (2017-2028)
2.2 Recombinant DNA Technology Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Recombinant DNA Technology Market Size by Region (2017-2022)
2.4 Global Recombinant DNA Technology Market Size Forecast by Region (2023-2028)
2.5 Global Top Recombinant DNA Technology Countries Ranking by Market Size
3 Recombinant DNA Technology Competitive by Company
3.1 Global Recombinant DNA Technology Revenue by Players
3.1.1 Global Recombinant DNA Technology Revenue by Players (2017-2022)
3.1.2 Global Recombinant DNA Technology Market Share by Players (2017-2022)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Recombinant DNA Technology Revenue
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2021
3.5 Global Recombinant DNA Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Revenue by Type (2017-2022)
4.2 Global Recombinant DNA Technology Forecasted Revenue by Type (2023-2028)
5 Global Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2017-2022)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Recombinant DNA Technology Revenue by Company (2020-2022)
6.2 North America Recombinant DNA Technology Revenue by Type (2017-2028)
6.3 North America Recombinant DNA Technology Revenue by Application (2017-2028)
6.4 North America Recombinant DNA Technology Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Revenue by Company (2020-2022)
7.2 Europe Recombinant DNA Technology Revenue by Type (2017-2028)
7.3 Europe Recombinant DNA Technology Revenue by Application (2017-2028)
7.4 Europe Recombinant DNA Technology Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant DNA Technology Revenue by Company (2020-2022)
8.2 Asia Pacific Recombinant DNA Technology Revenue by Type (2017-2028)
8.3 Asia Pacific Recombinant DNA Technology Revenue by Application (2017-2028)
8.4 Asia Pacific Recombinant DNA Technology Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Recombinant DNA Technology Revenue by Company (2020-2022)
9.2 Latin America Recombinant DNA Technology Revenue by Type (2017-2028)
9.3 Latin America Recombinant DNA Technology Revenue by Application (2017-2028)
9.4 Latin America Recombinant DNA Technology Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant DNA Technology Revenue by Company (2020-2022)
10.2 Middle East and Africa Recombinant DNA Technology Revenue by Type (2017-2028)
10.3 Middle East and Africa Recombinant DNA Technology Revenue by Application (2017-2028)
10.4 Middle East and Africa Recombinant DNA Technology Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Details
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Products and Services
11.1.4 Monsanto Company Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.1.5 Monsanto Company Recombinant DNA Technology SWOT Analysis
11.1.6 Monsanto Company Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Products and Services
11.2.4 Roche Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.2.5 Roche Recombinant DNA Technology SWOT Analysis
11.2.6 Roche Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Products and Services
11.3.4 Biogen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.3.5 Biogen Recombinant DNA Technology SWOT Analysis
11.3.6 Biogen Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Products and Services
11.4.4 Amgen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.4.5 Amgen Recombinant DNA Technology SWOT Analysis
11.4.6 Amgen Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Products and Services
11.5.4 Novartis Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.5.5 Novartis Recombinant DNA Technology SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Products and Services
11.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.6.5 Eli Lilly and Company Recombinant DNA Technology SWOT Analysis
11.6.6 Eli Lilly and Company Recent Developments
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Products and Services
11.7.4 GenScript Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.7.5 GenScript Recombinant DNA Technology SWOT Analysis
11.7.6 GenScript Recent Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Products and Services
11.8.4 Pfizer Inc. Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.8.5 Pfizer Inc. Recombinant DNA Technology SWOT Analysis
11.8.6 Pfizer Inc. Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Products and Services
11.9.4 Novo Nordisk Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.9.5 Novo Nordisk Recombinant DNA Technology SWOT Analysis
11.9.6 Novo Nordisk Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Products and Services
11.10.4 Sanofi Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.10.5 Sanofi Recombinant DNA Technology SWOT Analysis
11.10.6 Sanofi Recent Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Products and Services
11.11.4 Merck KGaA Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.11.5 Merck KGaA Recent Developments
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Products and Services
11.12.4 Profacgen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.12.5 Profacgen Recent Developments
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Products and Services
11.13.4 Biocon Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.13.5 Biocon Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Products and Services
11.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.14.5 GlaxoSmithKline Recent Developments
11.15 Cibus
11.15.1 Cibus Company Details
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Products and Services
11.15.4 Cibus Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.15.5 Cibus Recent Developments
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Details
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Products and Services
11.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.16.5 Horizon Discovery Group Recent Developments
11.17 New England Biolabs
11.17.1 New England Biolabs Company Details
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Products and Services
11.17.4 New England Biolabs Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022)
11.17.5 New England Biolabs Recent Developments
12 Recombinant DNA Technology Market Dynamics
12.1 Recombinant DNA Technology Market Trends
12.2 Recombinant DNA Technology Market Drivers
12.3 Recombinant DNA Technology Market Challenges
12.4 Recombinant DNA Technology Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Recombinant DNA Technology Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Recombinant DNA Technology Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Recombinant DNA Technology Revenue Market Share by Region (2017-2022)
Table 10. Global Recombinant DNA Technology Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Players (2017-2022)
Table 12. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2021)
Table 13. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Recombinant DNA Technology Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Recombinant DNA Technology Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Recombinant DNA Technology Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Recombinant DNA Technology Revenue Market Share by Type (2017-2022)
Table 21. Global Recombinant DNA Technology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Recombinant DNA Technology Revenue Market Share by Type (2023-2028)
Table 23. Global Recombinant DNA Technology Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Recombinant DNA Technology Revenue Market Share by Application (2017-2022)
Table 25. Global Recombinant DNA Technology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Application (2023-2028)
Table 27. North America Recombinant DNA Technology Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Recombinant DNA Technology Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Recombinant DNA Technology Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Recombinant DNA Technology Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Recombinant DNA Technology Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Recombinant DNA Technology Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Recombinant DNA Technology Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Recombinant DNA Technology Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Recombinant DNA Technology Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Recombinant DNA Technology Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Recombinant DNA Technology Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Recombinant DNA Technology Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Recombinant DNA Technology Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Recombinant DNA Technology Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Recombinant DNA Technology Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Recombinant DNA Technology Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Recombinant DNA Technology Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Recombinant DNA Technology Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Recombinant DNA Technology Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Recombinant DNA Technology Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Recombinant DNA Technology Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Recombinant DNA Technology Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Recombinant DNA Technology Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Recombinant DNA Technology Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Recombinant DNA Technology Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Recombinant DNA Technology Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Recombinant DNA Technology Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Recombinant DNA Technology Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Recombinant DNA Technology Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Recombinant DNA Technology Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Recombinant DNA Technology Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Recombinant DNA Technology Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Recombinant DNA Technology Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Recombinant DNA Technology Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Recombinant DNA Technology Revenue by Country (2023-2028) & (US$ Million)
Table 62. Monsanto Company Company Details
Table 63. Monsanto Company Business Overview
Table 64. Monsanto Company Recombinant DNA Technology Product and Services
Table 65. Monsanto Company Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 66. Monsanto Company Recombinant DNA Technology SWOT Analysis
Table 67. Monsanto Company Recent Developments
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Recombinant DNA Technology Product and Services
Table 71. Roche Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 72. Roche Recombinant DNA Technology SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Biogen Company Details
Table 75. Biogen Business Overview
Table 76. Biogen Recombinant DNA Technology Product and Services
Table 77. Biogen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 78. Biogen Recombinant DNA Technology SWOT Analysis
Table 79. Biogen Recent Developments
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Recombinant DNA Technology Product and Services
Table 83. Amgen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 84. Amgen Recombinant DNA Technology SWOT Analysis
Table 85. Amgen Recent Developments
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Recombinant DNA Technology Product and Services
Table 89. Novartis Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 90. Novartis Recombinant DNA Technology SWOT Analysis
Table 91. Novartis Recent Developments
Table 92. Eli Lilly and Company Company Details
Table 93. Eli Lilly and Company Business Overview
Table 94. Eli Lilly and Company Recombinant DNA Technology Product and Services
Table 95. Eli Lilly and Company Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 96. Eli Lilly and Company Recombinant DNA Technology SWOT Analysis
Table 97. Eli Lilly and Company Recent Developments
Table 98. GenScript Company Details
Table 99. GenScript Business Overview
Table 100. GenScript Recombinant DNA Technology Product and Services
Table 101. GenScript Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 102. GenScript Recombinant DNA Technology SWOT Analysis
Table 103. GenScript Recent Developments
Table 104. Pfizer Inc. Company Details
Table 105. Pfizer Inc. Business Overview
Table 106. Pfizer Inc. Recombinant DNA Technology Product and Services
Table 107. Pfizer Inc. Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 108. Pfizer Inc. Recombinant DNA Technology SWOT Analysis
Table 109. Pfizer Inc. Recent Developments
Table 110. Novo Nordisk Company Details
Table 111. Novo Nordisk Business Overview
Table 112. Novo Nordisk Recombinant DNA Technology Product and Services
Table 113. Novo Nordisk Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 114. Novo Nordisk Recombinant DNA Technology SWOT Analysis
Table 115. Novo Nordisk Recent Developments
Table 116. Sanofi Company Details
Table 117. Sanofi Business Overview
Table 118. Sanofi Recombinant DNA Technology Product and Services
Table 119. Sanofi Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 120. Sanofi Recombinant DNA Technology SWOT Analysis
Table 121. Sanofi Recent Developments
Table 122. Merck KGaA Company Details
Table 123. Merck KGaA Business Overview
Table 124. Merck KGaA Recombinant DNA Technology Product and Services
Table 125. Merck KGaA Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 126. Merck KGaA Recent Developments
Table 127. Profacgen Company Details
Table 128. Profacgen Business Overview
Table 129. Profacgen Recombinant DNA Technology Product and Services
Table 130. Profacgen Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 131. Profacgen Recent Developments
Table 132. Biocon Company Details
Table 133. Biocon Business Overview
Table 134. Biocon Recombinant DNA Technology Product and Services
Table 135. Biocon Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 136. Biocon Recent Developments
Table 137. GlaxoSmithKline Company Details
Table 138. GlaxoSmithKline Business Overview
Table 139. GlaxoSmithKline Recombinant DNA Technology Product and Services
Table 140. GlaxoSmithKline Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 141. GlaxoSmithKline Recent Developments
Table 142. Cibus Company Details
Table 143. Cibus Business Overview
Table 144. Cibus Recombinant DNA Technology Product and Services
Table 145. Cibus Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 146. Cibus Recent Developments
Table 147. Horizon Discovery Group Company Details
Table 148. Horizon Discovery Group Business Overview
Table 149. Horizon Discovery Group Recombinant DNA Technology Product and Services
Table 150. Horizon Discovery Group Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 151. Horizon Discovery Group Recent Developments
Table 152. New England Biolabs Company Details
Table 153. New England Biolabs Business Overview
Table 154. New England Biolabs Recombinant DNA Technology Product and Services
Table 155. New England Biolabs Recombinant DNA Technology Revenue in Recombinant DNA Technology Business (2017-2022) & (US$ Million)
Table 156. New England Biolabs Recent Developments
Table 157. Recombinant DNA Technology Market Trends
Table 158. Recombinant DNA Technology Market Drivers
Table 159. Recombinant DNA Technology Market Challenges
Table 160. Recombinant DNA Technology Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Sales Market Share by Type: 2021 VS 2028
Figure 2. Therapeutic Agent Features
Figure 3. Vaccine Features
Figure 4. Biotech Crops Features
Figure 5. Specialty Chemicals Features
Figure 6. Global Recombinant DNA Technology Sales Market Share by Application: 2021 VS 2028
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant DNA Technology Report Years Considered
Figure 11. Global Recombinant DNA Technology Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Recombinant DNA Technology Market Size 2017-2028 (US$ Million)
Figure 13. Global Recombinant DNA Technology Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Recombinant DNA Technology Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Recombinant DNA Technology Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Recombinant DNA Technology Market Share by Players in 2021
Figure 17. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2021
Figure 19. North America Recombinant DNA Technology Revenue Market Share by Company in 2021
Figure 20. North America Recombinant DNA Technology Revenue Market Share by Type (2017-2028)
Figure 21. North America Recombinant DNA Technology Revenue Market Share by Application (2017-2028)
Figure 22. North America Recombinant DNA Technology Revenue Share by Country (2017-2028)
Figure 23. U.S. Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Recombinant DNA Technology Revenue Market Share by Company in 2021
Figure 26. Europe Recombinant DNA Technology Revenue Market Share by Type (2017-2028)
Figure 27. Europe Recombinant DNA Technology Revenue Market Share by Application (2017-2028)
Figure 28. Europe Recombinant DNA Technology Revenue Share by Country (2017-2028)
Figure 29. Germany Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 30. France Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Recombinant DNA Technology Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Recombinant DNA Technology Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Recombinant DNA Technology Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Recombinant DNA Technology Revenue Share by Region (2017-2028)
Figure 38. China Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 41. India Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 43. China Taiwan Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Recombinant DNA Technology Revenue Market Share by Company in 2021
Figure 48. Latin America Recombinant DNA Technology Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Recombinant DNA Technology Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Recombinant DNA Technology Revenue Share by Country (2017-2028)
Figure 51. Mexico Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Recombinant DNA Technology Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Recombinant DNA Technology Revenue Share by Country (2017-2028)
Figure 58. Turkey Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 60. UAE Recombinant DNA Technology Revenue (2017-2028) & (US$ Million)
Figure 61. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 62. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 63. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 64. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 67. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 68. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 69. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 70. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 71. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 72. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 73. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 74. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 75. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 76. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 77. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs